For the readers interested in the stock health of GlycoMimetics Inc. (GLYC). It is currently valued at $2.87. When the transactions were called off in the previous session, Stock hit the highs of $2.88, after setting-off with the price of $2.60. Company’s stock value dipped to $2.60 during the trading on the day. When the trading was stopped its value was $2.56.Recently in News on December 12, 2022, GlycoMimetics Announces New Uproleselan Clinical Data in Both Frontline Unfit and Treated Secondary Acute Myeloid Leukemia presented at ASH Annual Meeting. GlycoMimetics, Inc. (Nasdaq: GLYC), a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today announced results from two investigator-sponsored trials studying uproleselan in patients with acute myeloid leukemia (AML). These results were presented at the 64th American Society of Hematology (ASH) Annual Meeting. You can read further details here
GlycoMimetics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $3.30 on 01/03/23, with the lowest value was $2.42 for the same time period, recorded on 01/06/23.
GlycoMimetics Inc. (GLYC) full year performance was 143.22%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, GlycoMimetics Inc. shares are logging -13.03% during the 52-week period from high price, and 462.75% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.51 and $3.30.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 534720 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the GlycoMimetics Inc. (GLYC) recorded performance in the market was -5.28%, having the revenues showcasing 394.83% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 149.90M, as it employees total of 52 workers.
Market experts do have their say about GlycoMimetics Inc. (GLYC)
During the last month, 0 analysts gave the GlycoMimetics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.47, with a change in the price was noted +2.07. In a similar fashion, GlycoMimetics Inc. posted a movement of +259.69% for the period of last 100 days, recording 449,895 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for GLYC is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical breakdown of GlycoMimetics Inc. (GLYC)
Raw Stochastic average of GlycoMimetics Inc. in the period of last 50 days is set at 83.46%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 63.25%. In the last 20 days, the company’s Stochastic %K was 45.66% and its Stochastic %D was recorded 45.73%.
Bearing in mind the latest performance of GlycoMimetics Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -5.28%. Additionally, trading for the stock in the period of the last six months notably improved by 300.67%, alongside a boost of 143.22% for the period of the last 12 months. The shares increased approximately by -4.97% in the 7-day charts and went down by 29.28% in the period of the last 30 days. Common stock shares were driven by 394.83% during last recorded quarter.